Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

Bipolar Androgen Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Principal Investigator: Chatta, Gurkamal S

A Phase 1/2 Study of EPI-7386 in Combination with
Enzalutamide Compared with Enzalutamide Alone in Subjects with Metastatic Castration-Resistant Prostate Cancer

Principal Investigator: Chatta, Gurkamal S

PHASE 1/2 STUDY OF REGN4336 (A PSMAXCD3 BISPECIFIC ANTIBODY) ADMINISTERED ALONE OR IN COMBINATION WITH CEMIPLIMAB IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER

Principal Investigator: Chatta, Gurkamal S

Weight loss interventions to reduce cancer progression in prostate cancer patients under active surveillance

Principal Investigator: Yeary, Karen H

NRG-GU010: PARALLEL PHASE III RANDOMIZED TRIALS OF GENOMIC RISK STRATIFIED UNFAVORABLE INTERMEDIATE RISK PROSTATE CANCER: DE-INTENSIFICATION AND INTENSIFICATION CLINICAL
TRIAL EVALUATION (GUIDANCE)

Principal Investigator: Kuettel, Michael R

NRG-GU011: A PHASE II DOUBLE-BLINDED, PLACEBO CONTROLLED TRIAL OF PROSTATE OLIGOMETASTATIC
RADIOTHERAPY WITH OR WITHOUT ANDROGEN
DEPRIVATION THERAPY IN OLIGOMETASTATIC PROSTATE
CANCER (NRG PROMETHEAN)

Principal Investigator: Kuettel, Michael R

NRG-GU009: PARALLEL PHASE III RANDOMIZED TRIALS FOR HIGH RISK PROSTATE CANCER EVALUATING DE-INTENSIFICATION FOR LOWER GENOMIC RISK AND INTENSIFICATION OF CONCURRENT THERAPY FOR HIGHER GENOMIC RISK WITH RADIATION (PREDICT-RT*)
*Prostate RNA Expression…

Principal Investigator: Kuettel, Michael R

Investigating the Correlation Between the Brain and Pelvic Floor Muscle Activity of
Patients who had or are Undergoing Robot-Assisted Radical Prostatectomy

Principal Investigator: Guru, Khurshid

Nutrition and Exercise Interventions to Reduce Androgen Deprivation Therapy-induced Obese Frailty in Survivors of Advanced Prostate Cancer

Principal Investigator: Chatta, Gurkamal S